• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

横纹肌溶解症相关早期急性肾损伤患者应用中分子截留滤器行连续性静脉-静脉血液透析时 NT-proBNP 和降钙素原的清除率。

Clearance of NT-proBNP and Procalcitonin during Continuous Venovenous Hemodialysis with the Medium Cutoff Filter in Patients with Rhabdomyolysis-Associated Early Acute Kidney Injury.

机构信息

Nephrology, Dialysis and Transplantation U, University Hospital City of Science and Health, CTO Hospital, Torino, Italy.

Department of Medical Sciences, University of Torino, Torino, Italy.

出版信息

Blood Purif. 2023;52(5):446-454. doi: 10.1159/000528861. Epub 2023 Mar 7.

DOI:10.1159/000528861
PMID:36882012
Abstract

INTRODUCTION

In polytrauma patients with AKI continuous venovenous hemodialysis (CVVHD) with medium cutoff membrane filters is commonly adopted to increase the removal of both myoglobin and inflammatory mediators, but its impact on increasing molecular weight markers of inflammation and cardiac damage is debated.

METHODS

Twelve critically ill patients with rhabdomyolysis (4 burns and 8 polytrauma patients) and early AKI requiring CVVHD with EMIc2 filter were tested for 72 h on serum and effluent levels for NT-proBNP, procalcitonin (PCT), myoglobin, C-reactive protein (CRP), alpha1-glycoprotein, albumin, and total protein.

RESULTS

The sieving coefficients (SCs) for proBNP and myoglobin were as higher as 0.5 at the start, decreased to 0.3 at the 2nd h, and then slowly declined to the final value of 0.25 and 0.20 at the 72nd h, respectively. PCT showed a negligible SC at the 1st h, a peak of 0.4 at the 12th h, and a final value of 0.3. SCs for albumin, alpha1-glycoprotein, and total protein were negligible. A similar trend was observed for the clearances (17-25 mL/min for proBNP and myoglobin; 12 mL/for PCT; <2 mL/min for albumin, alpha1-glycoprotein, and total protein). No correlation was found between systemic determinations and filter clearances of proBNP, PCT, and myoglobin. Net fluid loss/hour during CVVHD positively correlated with systemic myoglobin for all patients and NT-proBNP in the burn patients.

CONCLUSION

CVVHD with EMiC2 filter showed low clearances for NT-proBNP and procalcitonin. CVVHD did not significantly affect the serum levels of these biomarkers, which could be adopted in the clinical management of early CVVHD patients.

摘要

简介

在伴有急性肾损伤(AKI)的创伤患者中,常采用中分子截留膜过滤器进行连续静脉-静脉血液透析(CVVHD),以增加肌红蛋白和炎症介质的清除率,但对于增加炎症和心肌损伤的分子重量标志物的影响仍存在争议。

方法

对 12 例伴有横纹肌溶解症(4 例烧伤和 8 例多发伤患者)和早期 AKI 需行 CVVHD 的危重症患者,采用 EMIc2 过滤器进行了 72 小时的血清和流出液水平检测,以评估 NT-proBNP、降钙素原(PCT)、肌红蛋白、C 反应蛋白(CRP)、α1-糖蛋白、白蛋白和总蛋白。

结果

在开始时,proBNP 和肌红蛋白的筛系数(SCs)高达 0.5,在第 2 小时降至 0.3,然后缓慢下降至第 72 小时的最终值 0.25 和 0.20。PCT 在第 1 小时的 SC 可忽略不计,第 12 小时达到峰值 0.4,最终值为 0.3。白蛋白、α1-糖蛋白和总蛋白的 SC 可忽略不计。对于清除率(proBNP 和肌红蛋白为 17-25ml/min;PCT 为 12ml/min;白蛋白、α1-糖蛋白和总蛋白均<2ml/min),也观察到类似的趋势。在所有患者中,CVVHD 期间系统测定值与 proBNP、PCT 和肌红蛋白的滤器清除率之间无相关性。在烧伤患者中,CVVHD 期间的净液体丢失/小时与全身肌红蛋白和 NT-proBNP 呈正相关。

结论

采用 EMiC2 过滤器进行 CVVHD 对 NT-proBNP 和降钙素原的清除率较低。CVVHD 对这些生物标志物的血清水平没有显著影响,可用于早期 CVVHD 患者的临床管理。

相似文献

1
Clearance of NT-proBNP and Procalcitonin during Continuous Venovenous Hemodialysis with the Medium Cutoff Filter in Patients with Rhabdomyolysis-Associated Early Acute Kidney Injury.横纹肌溶解症相关早期急性肾损伤患者应用中分子截留滤器行连续性静脉-静脉血液透析时 NT-proBNP 和降钙素原的清除率。
Blood Purif. 2023;52(5):446-454. doi: 10.1159/000528861. Epub 2023 Mar 7.
2
Clearance of myoglobin by high cutoff continuous veno-venous hemodialysis in a patient with rhabdomyolysis: a case report.高截留量持续静静脉血液透析清除横纹肌溶解症患者肌红蛋白:一例报告
Hemodial Int. 2015 Jan;19(1):135-40. doi: 10.1111/hdi.12172. Epub 2014 Apr 27.
3
Clinical Assessment of Continuous Hemodialysis with the Medium Cutoff EMiC®2 Membrane in Patients with Septic Shock.中分子量 cutoff EMiC®2 膜连续性血液透析在感染性休克患者中的临床评估。
Blood Purif. 2022;51(11):912-922. doi: 10.1159/000522321. Epub 2022 Mar 9.
4
Procalcitonin and N-Terminal Pro-B-Type Natriuretic Peptide for Prognosis in Septic Acute Kidney Injury Patients Receiving Renal Replacement Therapy.降钙素原和 N 端脑利钠肽前体在接受肾脏替代治疗的脓毒症急性肾损伤患者中的预后价值。
Blood Purif. 2019;48(3):262-271. doi: 10.1159/000501388. Epub 2019 Jul 16.
5
Removal of Procalcitonin and Selected Cytokines during Continuous Veno-Venous Hemodialysis Using High Cutoff Hemofilters in Patients with Sepsis and Acute Kidney Injury.在脓毒症和急性肾损伤患者中使用高通量血液滤过器进行连续静脉-静脉血液透析时降钙素原和选定细胞因子的清除。
Blood Purif. 2018;46(2):153-159. doi: 10.1159/000488929. Epub 2018 Apr 27.
6
Clearance of inflammatory cytokines in patients with septic acute kidney injury during renal replacement therapy using the EMiC2 filter (Clic-AKI study).在使用 EMiC2 过滤器进行肾脏替代治疗时,清除脓毒症急性肾损伤患者的炎症细胞因子(Clic-AKI 研究)。
Crit Care. 2021 Jan 28;25(1):39. doi: 10.1186/s13054-021-03476-x.
7
Rapid and Effective Elimination of Myoglobin with CytoSorb® Hemoadsorber in Patients with Severe Rhabdomyolysis.细胞吸附剂 CytoSorb® 快速有效清除横纹肌溶解症患者肌红蛋白。
Blood Purif. 2024;53(2):88-95. doi: 10.1159/000534479. Epub 2023 Nov 2.
8
Myoglobin clearance with continuous veno-venous hemodialysis using high cutoff dialyzer versus continuous veno-venous hemodiafiltration using high-flux dialyzer: a prospective randomized controlled trial.高截留系数在线血液透析与高通量在线血液透析滤过清除肌红蛋白的前瞻性随机对照研究。
Crit Care. 2020 Nov 11;24(1):644. doi: 10.1186/s13054-020-03366-8.
9
Myoglobin removal using high-volume high-flux hemofiltration in patients with oliguric acute kidney injury.使用大体积高通量血液滤过清除少尿型急性肾损伤患者的肌红蛋白。
Blood Purif. 2013;36(2):107-11. doi: 10.1159/000354727. Epub 2013 Sep 25.
10
CVVHD results in longer filter life than pre-filter CVVH: Results of a quasi-randomized clinical trial.CVVHD 比预滤 CVVH 更能延长滤器寿命:一项准随机临床试验结果。
PLoS One. 2023 Jan 11;18(1):e0278550. doi: 10.1371/journal.pone.0278550. eCollection 2023.

引用本文的文献

1
Procalcitonin levels in septic and nonseptic subjects with AKI and ESKD prior to and during continuous kidney replacement therapy (CKRT).在接受连续性肾脏替代治疗(CKRT)之前及期间,患有急性肾损伤(AKI)和终末期肾病(ESKD)的脓毒症和非脓毒症患者的降钙素原水平。
Crit Care. 2025 Apr 30;29(1):171. doi: 10.1186/s13054-025-05414-7.
2
Kidney replacement and conservative therapies in rhabdomyolysis: a retrospective analysis.横纹肌溶解症中的肾脏替代治疗与保守疗法:回顾性分析。
BMC Nephrol. 2024 Mar 14;25(1):96. doi: 10.1186/s12882-024-03536-8.
3
Medium cut-off dialyzer for middle molecular uremic toxins in AKI and chronic dialysis.
中分子尿毒症毒素的中截留量透析器在急性肾损伤和慢性透析中的应用。
J Nephrol. 2024 Jan;37(1):23-37. doi: 10.1007/s40620-023-01771-0. Epub 2023 Oct 16.
4
Safety and Metabolic Tolerance of Citrate Anticoagulation in Critically Ill Polytrauma Patients with Acute Kidney Injury Requiring an Early Continuous Kidney Replacement Therapy.在需要早期连续性肾脏替代治疗的急性肾损伤多发伤重症患者中柠檬酸盐抗凝的安全性和代谢耐受性
Biomedicines. 2023 Sep 19;11(9):2570. doi: 10.3390/biomedicines11092570.